Navigation Links
ShangPharma's Biologics Division Announces Accelerated Achievement of Milestones for Two Multi-Stage Projects
Date:8/11/2011

SHANGHAI, Aug. 11, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it has achieved the initial milestones for two multi-staged projects in its biologics division, which portends strong growth for this segment in 2011.

The initial milestones were achieved for two oncology projects that are under development for a major U.S.-based pharmaceutical company. ShangPharma launched the projects at the beginning of this year and reached these milestones earlier than anticipated. As a result, the Company is advancing into the second phase of development ahead of schedule. ShangPharma is also conducting another multi-stage project in immunology for the same client, and expects to reach the initial milestone in the near-term.

Over the past year, ShangPharma has greatly enhanced its technological platforms in biologics research, allowing for faster delivery of high quality R&D work. Currently, it possesses a complete platform for the preclinical development of therapeutic antibodies that can support early-stage target validation through the delivery of potential drug candidates. These broadened service offerings have resulted in a significant increase in its biologics division's pipeline for additional projects that are expected to start in the near-term. The Company is gaining wider acceptance due to its ability to perform integrated programs and it expects to enter into additional contracts with new customers including a top 20 global pharmaceutical company, a U.S.-based biotechnology company and a large domestic Chinese pharmaceutical company, during the second half of 2011. The Company also plans to have close to 100 employees in the biologics division by the end of 2011.  

Michael Xin Hui, foun
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
2. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
3. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
4. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
5. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
6. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
7. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
8. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
9. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
10. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
11. CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 28, 2015 The new Rx ... Public Policy Institute (PPI) shows a number of ... prices going up as much as 1,000%. Overall, retail ... Americans fell an average of 4% in 2013. Although ... past several years, the latest annual data available showed ...
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ...   report to their offering.  ... provides a worldwide strategic overview of the ... regions, market segments and product categories. , ...
(Date:5/27/2015)...  Actavis plc (NYSE: ACT ) announced ... Food and Drug Administration (FDA) as a twice-daily, ... syndrome with diarrhea (IBS-D). VIBERZI (eluxadoline) has mixed ... agonist, a delta receptor antagonist, and a kappa ... "The FDA,s approval of VIBERZI ...
Breaking Medicine Technology:Generic Drug Prices Dropping More Slowly According to AARP Report 2Generic Drug Prices Dropping More Slowly According to AARP Report 3Generic Drug Prices Dropping More Slowly According to AARP Report 4Generic Drug Prices Dropping More Slowly According to AARP Report 5Global Orthopedics Market Strategies 2015 2Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 2Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 3Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 4Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 5
... Nov. 10, 2011 Throughout the healthcare industry, compliance ... relations (PTR) groups are tightening as increased regulations intensify ... the pace of activity cycles are slowing and more ... Nearly 90% of pharma PTR groups feel ...
... HONOLULU, Nov. 10, 2011 Eli Lilly and Company ... Executive Officer John C. Lechleiter, Ph.D., today said new ... bring innovation to patients are needed to assure improved ... Lechleiter,s comments come as the United States hosts ...
Cached Medicine Technology:Restrictive Compliance Environment Weakens Professional and Trade Relations Group Impact 2Lilly CEO Lechleiter Outlines Opportunities for Improved Health and Economic Growth in Asia-Pacific Region 2Lilly CEO Lechleiter Outlines Opportunities for Improved Health and Economic Growth in Asia-Pacific Region 3Lilly CEO Lechleiter Outlines Opportunities for Improved Health and Economic Growth in Asia-Pacific Region 4
(Date:5/28/2015)... FL (PRWEB) May 28, 2015 The ... a case study featuring Healthcare IQ. Members of the ... IQ senior management team to develop the case study ... of healthcare analytics. , The case study, ‘Healthcare IQ: ... Healthcare IQ from its beginning as a hospital financial ...
(Date:5/28/2015)... Orem, UT—Dymicron, Inc., (dymicron.com) confirmed the successful completion ... cervical total disc replacement device. The two surgeries were ... the American Institute of Minimally Invasive Surgery (AIMIS) in ... the implantation of the Dymicron devices,” said Dr. William ... of Neurosurgery for the University Medical Center, Las Vegas, ...
(Date:5/28/2015)... May 28, 2015 Aureus Medical Group ... nurse practitioner jobs, has announced that it will participate ... Practitioners’ 2015 National Conference to be held June 9-14, ... offers educational programming, networking opportunities, and exhibits with products ... Advanced Practice division will be available to speak ...
(Date:5/28/2015)... Peggy J. Lynam, PT, DPT, NCS from New ... Therapy Association House of Delegates for the New York Physical ... This will be her second term. The Chief ... principle spokesperson for the Chapter delegation and presides over any ... Assembly may direct the Chief Delegate to present matters to ...
(Date:5/27/2015)... Gravity and volume loss in the ... Management Expert™, Holly CaSaroll, is excited to introduce a ... the mid face, without surgical intervention, and without downtime. ... a FDA approved procedure that can lift skin using ... is a new more lifting formula than its predecessor ...
Breaking Medicine News(10 mins):Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2Health News:Skin Expert Holly CaSaroll Announces New Cutting Edge Results with RadiessePlus Filler Available at Detroit Skin and Wellness Clinic 2
... 24 (HealthDay News) -- Exclusive breast-feeding of infants for ... developing the itchy skin disorder known as eczema in ... infant receives only breast milk, with no additional food ... breast-feeding up to 6 months of age is recommended ...
... York, NY, August 24, 2011 Nearly three-quarters (72%) of people ... over the last two years said that they skipped needed ... cost, according to a new Commonwealth Fund report. The ... debt, compared to about half (49%) who lost jobs but ...
... , Governments in the UK, US and Canada are undermining ... smoking, a report by public health researchers says. The paper, ... argues that films with tobacco imagery should be ineligible for ... conflict with public health goals. Earlier research shows that ...
... News) -- Accidental exposure to highly toxic chemotherapy drugs ... a new study finds. Researchers surveyed 1,339 oncology ... infusion centers and found that nearly 17 percent said ... drugs. In the United States, about 84 percent ...
... HealthDay Reporter , TUESDAY, Aug. 23 (HealthDay News) ... jobless men in what,s been dubbed the "mancession" are ... support their working partners, a small study suggests. ... conducted intensive interviews of 19 recently unemployed men. She ...
... , TUESDAY, Aug. 23 (HealthDay News) -- A common ... worsen over time and may lead to an increased risk ... diastolic dysfunction, which often comes with advancing age, the heart,s ... and is accompanied by elevated filling pressures. The new ...
Cached Medicine News:Health News:Breast-Feeding Won't Prevent Kids' Eczema, Researchers Say 2Health News:Three quarters of those who have lost jobs and health insurance are skipping needed health care 2Health News:Three quarters of those who have lost jobs and health insurance are skipping needed health care 3Health News:Three quarters of those who have lost jobs and health insurance are skipping needed health care 4Health News:Government subsidies to the US film industry promote youth smoking, argue researchers 2Health News:Nurses at Risk for Accidental Exposure to Chemo Drugs: Study 2Health News:In Tough Times, Jobless Men Embrace Housework 2Health News:In Tough Times, Jobless Men Embrace Housework 3Health News:Common Heart Dysfunction Can Help Bring on Heart Failure 2
... less than thirty pounds, the EUB 405 ... quality. Compatible with a wide range of ... solution for a variety of clinical settings. ... easy to operate. It includes an alphanumeric ...
... fast, the HI VISION 8500 diagnostic ... with user-oriented operation for exceptional imaging ... package consists of advanced techniques for ... COMPOUND multi-angle spatial compounding, wideband pulse-inversion, ...
... is a radial-type endoscope with a built-in ... a flicker-free, high-resolution image under echo. It ... for direct visual observation. The EG-3630UR has ... an endoscope as well as exceptional ultrasound ...
... The ACL 7000 coagulation analyzer is ... that needs a full range of ... You'll have access to a broad ... APCR-Leiden. Plus, you'll benefit from an ...
Medicine Products: